NutriBand (NTRB) EBITDA Margin (2018 - 2026)
NutriBand's (NTRB) quarterly EBITDA Margin came in at 203.57% in Q3 2026, up 11826.0% year-over-year from N/an in Q3 2025, and up 29.66% quarter-over-quarter from 289.42% in Q2 2026.
Powered by 
Analysis
NutriBand (NTRB) EBITDA Margin (2018 - 2026) Analysis & Trends
NutriBand has disclosed EBITDA Margin across 9 years of filings, most recently posting 203.57% for Q3 2026.
- In Q3 2026, EBITDA Margin rose 11826.0% year-over-year to 203.57%; the TTM figure through Jul 2026 stood at 435.58% (down 3208.0% YoY), while the FY2026 annual figure was 408.41%, up 7229.0% from the prior year.
- EBITDA Margin came in at 203.57% for Q3 2026 at NutriBand, up from 289.42% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 125.65% in Q3 2023 to a low of 1121.3% in Q4 2025.
- Average EBITDA Margin over 5 years is 362.68%, with a median of 254.78% recorded in 2026.
- Year-over-year, EBITDA Margin sank 90035 bps in 2025 and soared 61057 bps in 2026.
- Over 5 years, EBITDA Margin stood at 173.38% in 2022, then slumped by 132 bps to 402.84% in 2023, then soared by 45 bps to 220.94% in 2024, then slumped by 408 bps to 1121.3% in 2025, then jumped by 82 bps to 203.57% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 203.57% in Q3 2026, 289.42% in Q2 2026, and 254.78% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -5.58% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 0.17% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 4.69% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 16.30% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 25.95% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 15.21% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -134.08% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 21.60% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 9.72% |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | -203.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -203.57% |
| Apr 30, 2026 | -289.42% |
| Jan 31, 2026 | -254.78% |
| Oct 31, 2025 | -1,121.30% |
| Jul 31, 2025 | -321.83% |
| Apr 30, 2025 | -211.78% |
| Jan 31, 2025 | -865.34% |
| Oct 31, 2024 | -220.94% |
| Jul 31, 2024 | -318.35% |
| Apr 30, 2024 | -462.50% |
| Jan 31, 2024 | -249.01% |
| Oct 31, 2023 | -402.84% |
| Jul 31, 2023 | -125.65% |
| Apr 30, 2023 | -213.42% |
| Jan 31, 2023 | -319.13% |
| Oct 31, 2022 | -173.38% |
| Jul 31, 2022 | -226.73% |
| Apr 30, 2022 | -143.51% |
| Jan 31, 2022 | -767.47% |
| Oct 31, 2021 | -543.55% |